These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8419197)

  • 41. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle.
    van Santbrink EJ; Hop WC; van Dessel TJ; de Jong FH; Fauser BC
    Fertil Steril; 1995 Jul; 64(1):37-43. PubMed ID: 7789578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2920-5. PubMed ID: 16720653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.
    Schipper I; de Jong FH; Fauser BC
    Hum Reprod; 1998 Jun; 13(6):1442-8. PubMed ID: 9688368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
    Farhi J; Jacobs HS
    Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.
    Wiser A; Shehata F; Holzer H; Hyman JH; Shalom-Paz E; Son WY; Tulandi T
    J Reprod Med; 2013; 58(5-6):219-23. PubMed ID: 23763006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
    Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
    J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Porcine follicle-stimulating hormone treatment of gilts during an altrenogest-synchronized follicular phase: effects on follicle growth, hormone secretion, ovulation, and fertilization.
    Guthrie HD; Pursel VG; Wall RJ
    J Anim Sci; 1997 Dec; 75(12):3246-54. PubMed ID: 9419999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
    Schoot DC; Hop WC; Pache TD; de Jong FH; Fauser BC
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle.
    Hee JP; MacNaughton J; Bangah M; Zissimos M; McCloud PI; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1993 May; 76(5):1340-3. PubMed ID: 8496327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related changes in antral follicle count among women with and without polycystic ovaries.
    Al-Sunaidi M; Al-Mahrizi S; Tan SL; Tulandi T
    Gynecol Obstet Invest; 2007; 64(4):199-203. PubMed ID: 17664881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
    Al-Ojaimi EH
    Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
    Sagnella F; Apa R; Guido M; Villa P; Spadoni V; Miceli F; Lanzone A
    Fertil Steril; 2009 May; 91(5):1857-63. PubMed ID: 18538325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.